206 SAFFRON: Savolitinib + Osimertinib vs Chemotherapy in EGFRm NSCLC with MET Overexpression/Amplification Post-OsimertinibColin Lindsay,Wanning Xu,Aino Telaranta-Keerie, Nan Jia,Ryan J Hartmaier,Shun LuLung Cancer(2024)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要